The Biotechnology Innovation Organization (BIO) will be holding its annual BIO International Convention June 4-7, 2018 in Boston, MA. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. The BIO International Convention serves to educate the public and policymakers about biotechnology, while fostering partnering meetings and other business development activities to keep the biotech industry growing.
Descriptions of the Convention's 125+ Breakout Sessions and eight Super Sessions can be obtained here. Among the sessions that may be of interest to Patent Docs readers are:
Monday, June 4
Intellectual Property Track Opening Plenary with Andrei Iancu, Under Secretary of Commerce for IP and Director, USPTO (Intellectual Property Track) -- 1:00 to 2:15 pm (Room 259A, Level 2)
Has Big Pharma Fixed its Broken Innovation Model? (Business Development & Finance Track) -- 1:00 to 2:15 pm (Room 257AB, Level 2)
Tuesday, June 5
FDA Town Hall (Regulatory Innovation Track) -- 11:00 am to 12:00 pm (Room 207, Level 2)
Hatch-Waxman ANDA Cases and IPRs (Intellectual Property Track) -- 3:00 to 4:00 pm (Room 208, Level 2)
Global Leadership Forum: Is Biotechnology Innovation Globally Sustainable? (Emerging Opportunities in Global Markets Track) -- 3:00 to 4:00 pm (Room 204AB, Level 2)
IP Issues in Rare Diseases: Addressing the Unmet Need (Intellectual Property Track) -- 4:15 to 5:15 pm (Room 208, Level 2)
The Changing Face of Academic Technology Transfer (Translational Research Track) -- 4:15 to 5:15 pm (Room 206AB, Level 2)
Wednesday, June 6
Functional Antibody Patents Are Dead: Long Live Functional Antibody Patents (Intellectual Property Track) -- 11:00 am to 12:00 pm (Room 208, Level 2)
Are Your Pharmaceutical Patents at Risk? (Intellectual Property Track) -- 1:45 to 2:45 pm (Room 208, Level 2)
Legal Certainty at an Affordable Price – the European Opposition Procedure (Intellectual Property Track) -- 3:00 to 4:00 pm (Room 208, Level 2)
Using America’s Seed Fund (SBIR/STTR) and NIH Technology Transfer to Accelerate Technology Development and Secure Follow-On Investments (Business Development & Finance Track) -- 3:00 to 4:00 pm (Room 252AB, Level 2)
State Universities, Indian Tribes, and Biotech Patent Law (Intellectual Property Track) -- 4:15 to 5:15 pm (Room 208, Level 2) -- panel includes Patent Docs author Kevin Noonan
Thursday, June 7
Fireside Chat with Dr. Scott Gottlieb, Commissioner, U.S. Food and Drug Administration -- 9:00 to 9:45 am (Room 253ABC, Level 2)
As part of the Convention, more than 1,800 biotech companies, organizations, and institutions will participate in the BIO Exhibition. A searchable list of exhibitors can be found here. Information regarding registration and pricing can be obtained here. Patent Docs authors Donald Zuhn, Kevin Noonan, and Andrew Williams will be attending BIO as part of the MBHB contingent. Patent Docs readers who may be attending BIO are encouraged to stop by the MBHB booth (#2620).
In addition, the Docs will be attending the MBHB reception at Black Rose Irish Pub (160 State Street, Boston) on Tuesday, June 5 from 8:00 pm to 1:00 am. Additional information about the reception, including invitations for the event, can be picked up at the MBHB booth.